The patterns of response of 11 regimens for infantile spasms

[1]  F. Yin,et al.  Next‐generation sequencing improves treatment efficacy and reduces hospitalization in children with drug‐resistant epilepsy , 2018, CNS neuroscience & therapeutics.

[2]  John Paul Leach,et al.  Faculty Opinions recommendation of ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[3]  K. Xia,et al.  Novel West syndrome candidate genes in a Chinese cohort , 2018, CNS neuroscience & therapeutics.

[4]  Patrick Kwan,et al.  Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study , 2017, JAMA neurology.

[5]  C. Chen,et al.  Effectiveness and Safety of Different Once-Daily Doses of Adrenocorticotropic Hormone for Infantile Spasms , 2017, Pediatric Drugs.

[6]  Edouard Hirsch,et al.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.

[7]  M. Likeman,et al.  Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial , 2017, The Lancet Neurology.

[8]  M. Chang,et al.  Efficacy of Treatments for Infantile Spasms: A Systematic Review , 2017, Clinical neuropharmacology.

[9]  M. Nair,et al.  Infantile spasms: A prognostic evaluation , 2016, Annals of Indian Academy of Neurology.

[10]  Sucheta Joshi,et al.  Response to treatment in a prospective national infantile spasms cohort , 2016, Annals of neurology.

[11]  E. Mizrahi,et al.  Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics , 2015, Epilepsia.

[12]  E. Wirrell,et al.  How should children with West syndrome be efficiently and accurately investigated? Results from the National Infantile Spasms Consortium , 2015, Epilepsia.

[13]  P. Striano,et al.  Infantile spasms syndrome, West syndrome and related phenotypes: What we know in 2013 , 2014, Brain and Development.

[14]  R. Riikonen.  Recent Advances in the Pharmacotherapy of Infantile Spasms , 2014, CNS Drugs.

[15]  J. Osborne,et al.  Treatment of infantile spasms. , 2013, The Cochrane database of systematic reviews.

[16]  H. Oguni,et al.  A long-term, clinical study on symptomatic infantile spasms with focal features , 2013, Brain and Development.

[17]  Deborah M. Miller,et al.  Report of the Guideline Development Subcommittee of the American Academy of Neurology , 2013 .

[18]  Hui Yang,et al.  Surgical treatment for epilepsy in 17 children with tuberous sclerosis-related West syndrome , 2012, Epilepsy Research.

[19]  M. Mackay,et al.  Evidence-based guideline update: Medical treatment of infantile spasms , 2012, Neurology.

[20]  J D Norrie,et al.  Patterns of treatment response in newly diagnosed epilepsy , 2012, Neurology.

[21]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[22]  S. Cash,et al.  Revising the “Rule of Three” for inferring seizure freedom , 2012, Epilepsia.

[23]  Patrick Kwan,et al.  Combination Therapy in Epilepsy , 2012, Drugs.

[24]  Dieter Schmidt,et al.  Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma , 2011, Epilepsia.

[25]  Wei Zhao,et al.  Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China. , 2010, Clinical therapeutics.

[26]  R. Riikonen,et al.  Favourable prognostic factors with infantile spasms. , 2008, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[27]  M. Brodie,et al.  Selection of antiepileptic drugs in adults. , 2009, Neurologic clinics.

[28]  M. Funatsuka,et al.  Extremely low-dose ACTH step-up protocol for West syndrome: Maximum therapeutic effect with minimal side effects , 2006, Brain and Development.

[29]  M. Mackay,et al.  CME Practice Parameter : Medical Treatment of Infantile Spasms , 2004 .

[30]  R. Riikonen.  Long-term outcome of patients with West syndrome , 2001, Brain and Development.

[31]  R. Nabbout.  A Risk-Benefit Assessment of Treatments for Infantile Spasms , 2001, Drug safety.

[32]  光生 島田,et al.  肝切除における術前ステロイド投与の有用性 Randomized Prospective Study , 2000 .

[33]  M. Cilio,et al.  Vigabatrin Versus ACTH as First‐Line Treatment for Infantile Spasms: A Randomized, Prospective Study , 1997, Epilepsia.

[34]  I. Jambaqué,et al.  Predicting Favorable Outcome in Idiopathic West Syndrome , 1993, Epilepsia.

[35]  L. Cowan,et al.  The Epidemiology and Natural History of Infantile Spasms , 1991, Journal of child neurology.

[36]  R. Riikonen,et al.  Incidence and Aetiology of Infantile Spasms from 1960 to 1976: a Population Study in Finland , 1979, Developmental medicine and child neurology.